Correction to: Prevalence and factors associated with inappropriate dosing of apixaban and rivaroxaban in hospitalized older adults with atrial fibrillation: a cross‑sectional study

Drugs Aging. 2024 Jan;41(1):81. doi: 10.1007/s40266-023-01088-4.

Théodore Decaix^{1

2}, Kenza Kemache³, Pierre Gay³, Olivier Laprévote^{4

5}, Flora Ketz³, Éric Pautas^{3

6

7}

¹ Acute Geriatrics Unit, Charles Foix Hospital, APHP Sorbonne University, Ivry-sur-Seine, France. theodore.decaix@aphp.fr.
² CNRS, CitCoM, Paris-Cité University, 75006, Paris, France. theodore.decaix@aphp.fr.
³ Acute Geriatrics Unit, Charles Foix Hospital, APHP Sorbonne University, Ivry-sur-Seine, France.
⁴ CNRS, CitCoM, Paris-Cité University, 75006, Paris, France.
⁵ Department of biology, 15-20 National Hospital Center of Ophtalmology, Paris, France.
⁶ Therapeutic Innovations in Hemostasis, Inserm UMR-S 1140, Paris-Cité University, Paris, France.
⁷ Medical School, Sorbonne University, Paris, France.

No abstract available

Publication types